Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Dan G Halpern
Job title: MD
Personal History Dr Dan G. Halpern is a cardiologist based in the New York area. He is an Assistant Professor in the Department of Medicine at NYU Grossman School of Medicine and the Medical Director of the Adult Congenital Heart Disease Program at NYU Langone Health. “I have wanted to be a doctor since I was a child,” he says. Prior to becoming a physician, he served as a medic in the Army… View more
Job title: Consultant Cardiologist and Director of the Hypertension Service
Sex Differences in Imaging for Structural Heart Disease
Author(s): Rowa H Attar Added: 4 months ago

Imaging & Diagnostics

Intervention
ESC 25 Discussion: 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
Author(s): Harriette Van Spall , Michael Andrew Borger Added: 9 months ago
ESC Congress 2025 - Dr Harriette Van Spall (McMaster University, Canada) sits down with Professor Michael Borger (University of Leipzig Heart Center, Germany), Co-Chair of the newly released 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.The new guidelines bring together the latest evidence and expert consensus on how to diagnose, evaluate, and treat patients with valvular… View more

Guidelines & Statements

Imaging & Diagnostics
TMVR in Patients with Multivalvular Heart Disease with Dr Kimberly Holst
Author(s): Kimberly Holst Added: 7 months ago
Navigate the strategic complexities of transcatheter mitral valve replacement in multivalvular disease with Dr Kimberly HolstThis presentation, part of Women As One's comprehensive Structural Interventions track, provides a systematic framework for approaching multivalvular heart disease. The presentation establishes the foundational principle of strategic intervention sequencing in high-risk… View more

Intervention
EuroPCR 26: VESALIUS-CV: Evolocumab in Stented Patients Without Prior MI
Author(s): Brian Bergmark Added: 2 weeks ago
EuroPCR 2026 – Dr Brian Bergmark (Brigham and Women's Hospital, Boston, MA, US) joins us to discuss findings from the VESALIUS-CV trial, examining the effect of evolocumab in patients who have undergone coronary stenting but have no prior myocardial infarction or stroke.VESALIUS-CV is a double-blind, randomised, placebo-controlled, multicentre phase 3 trial enrolling 12,301 high-cardiovascular… View more

Intervention
Left Main Disease: The Last Frontier for Medical Therapy in Stable CAD?
Author(s): Armin Arbab-Zadeh , Michelle Graham , Hector M Garcia-Garcia , et al Added: 9 months ago

Intervention

Prevention & Chronic Conditions
Cardiac Intervention During Pregnancy
Author(s): Alexandra Frogoudaki , Ahmed Krimly Added: 6 months ago

Inherited and Congenital Cardiac Conditions

Intervention
Market Watch: Abbott and the Changing Landscape of Structural Heart
Author(s): Lars Søndergaard Added: 1 week ago
In this Market Watch interview, Brad Wilson speaks with Professor Lars Søndergaard, Chief Medical Officer and Divisional Vice President, Medical Affairs for Abbott Structural Heart, about how transcatheter therapy has matured across the aortic, mitral and tricuspid space over the past two decades.The discussion traces the trajectory of TAVR from the first commercial European cases in 2006 to… View more

Intervention